10.05
0.07 (0.7%)
0.07 (0.7%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sorrento Therapeutics Inc | SRNE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.07 | 0.7% | 10.05 | 05:35:37 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 9.98 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 10.00 | 10.04 | 0.04 | - | - |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 53 | 3,553 | 15,514,087 | 1.55 - 21.26 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 05:29:41 | formt | 400 | $ 10.05 | USD |
Sorrento Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 2.75B | 273.70M | 268.91M | $ 31.43M | $ - | -2.20 | -6.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Sorrento Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SRNE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.15 | 10.72 | 8.02 | 9.63 | 33,922,327 | 1.90 | 23.31% |
| 1 Month | 7.94 | 10.72 | 6.575 | 8.39 | 16,863,015 | 2.11 | 26.57% |
| 3 Months | 7.13 | 10.72 | 5.17 | 7.68 | 15,327,523 | 2.92 | 40.95% |
| 6 Months | 8.07 | 21.26 | 5.17 | 10.26 | 27,700,641 | 1.98 | 24.54% |
| 1 Year | 4.16 | 21.26 | 1.55 | 8.15 | 24,173,842 | 5.89 | 141.59% |
| 3 Years | 6.65 | 21.26 | 1.39 | 7.54 | 9,832,374 | 3.40 | 51.13% |
| 5 Years | 6.10 | 21.26 | 1.39 | 7.37 | 6,170,466 | 3.95 | 64.75% |
Sorrento Therapeutics Description
| Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases. The antibody technologies target various locations: extracellular, intracellular, and membrane-bound antigens. The product portfolio consists of BioSimilar/BioBetter antibodies, CAR-T programs for treatment of solid tumors, adoptive cellular therapies, immuno-oncology mAbs, and antibody drug conjugates. |
